The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Results from VERONICA: A randomized, phase II study of second-/third-line venetoclax (VEN) + fulvestrant (F) versus F alone in estrogen receptor (ER)-positive, HER2-negative, locally advanced, or metastatic breast cancer (LA/MBC).
 
Geoffrey J Lindeman
Consulting or Advisory Role - Abbvie
Research Funding - Abbvie (Inst); Amgen (Inst); Pfizer (Inst); Roche (Inst)
Patents, Royalties, Other Intellectual Property - Abbvie (Inst); Roche/Genentech (Inst)
Other Relationship - Roche
 
Rebecca Bowen
Honoraria - GlaxoSmithKline
Consulting or Advisory Role - AstraZeneca; Clovis Oncology
Other Relationship - Roche
 
Katarzyna Joanna Jerzak
Honoraria - Amgen; Apobiologix; AstraZeneca; Eisai; Genomic Health; Knight Therapeutics; Lilly; Merck; Myriad Genetics; Novartis; Pfizer; Purdue Pharma; Roche
Consulting or Advisory Role - Amgen; Apobiologix; AstraZeneca; Eisai; Genomic Health; Knight Therapeutics; Lilly; Merck; Myriad Genetics; Myriad Genetics; Novartis; Pfizer; Purdue Pharma; Roche
Research Funding - AstraZeneca; Lilly
Patents, Royalties, Other Intellectual Property - I am the lead inventor on a patent for the use of dronedarone and its structural derivatives as cancer therapies.
Other Relationship - Roche
 
Xinni Song
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Merck Serono; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Merck (Inst); Novartis (Inst); Roche Canada (Inst); Syneos Health (Inst)
Travel, Accommodations, Expenses - Novartis
 
Thomas Decker
Consulting or Advisory Role - Novartis
 
Frances M. Boyle
Honoraria - Eisai; Lilly; Roche
Consulting or Advisory Role - Lilly; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Novartis
Other Relationship - Breast Cancer Network of Australia; Clinical Oncology Society of Australia (COSA); Pamgene; Paxman
(OPTIONAL) Uncompensated Relationships - Paxman; Paxman
 
Steven L. McCune
Speakers' Bureau - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb; Roche/Genentech
Other Relationship - Roche (Inst)
 
Anne Armstrong
Stock and Other Ownership Interests - AstraZeneca (I)
Travel, Accommodations, Expenses - Lilly; MSD
Other Relationship - Roche
 
Catherine M. Shannon
Consulting or Advisory Role - AstraZeneca; Roche
Speakers' Bureau - AstraZeneca; Roche
Travel, Accommodations, Expenses - Novartis
 
Gianfilippo Bertelli
Consulting or Advisory Role - Myriad Pharmaceuticals; Roche
Travel, Accommodations, Expenses - Roche
Other Relationship - Roche
 
Tharu M Fernando
Employment - Genentech
Stock and Other Ownership Interests - Roche
Travel, Accommodations, Expenses - Genentech
Other Relationship - Roche
 
Rupal Desai
Employment - Roche/Genentech
Stock and Other Ownership Interests - Roche/Genentech
Other Relationship - Roche
 
Kushagra Gupta
Employment - IQVIA
Other Relationship - Roche
 
Jerry Y. Hsu
Employment - F. Hoffmann LaRoche; Genentech
Stock and Other Ownership Interests - F. Hoffmann LaRoche; Genentech
Other Relationship - Roche
 
Aulde Flechais
Employment - F. Hoffmann LaRoche
Leadership - F. Hoffmann LaRoche
Stock and Other Ownership Interests - F. Hoffmann LaRoche
Honoraria - F. Hoffmann LaRoche
Consulting or Advisory Role - F. Hoffmann LaRoche
Travel, Accommodations, Expenses - F. Hoffmann LaRoche
Other Relationship - Roche
 
Aditya Bardia
Consulting or Advisory Role - bioTheranostics; Daiichi Sankyo/Astra Zeneca; Foundation Medicine; Genentech; Genentech/Roche (Inst); Immunomedics; Immunomedics (Inst); Innocrin Pharma (Inst); Merck; Novartis; Novartis (Inst); Pfizer; Pfizer (Inst); Philips Healthcare; Puma Biotechnology; Radius Health; Radius Health (Inst); Sanofi; Spectrum Pharmaceuticals
Research Funding - AstraZeneca/Daiichi Sankyo (Inst); Genentech (Inst); Immunomedics (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Radius Health (Inst); Sanofi (Inst)